Abstract
Pain is a common symptom in a variety of medical and neurologic diseases. Frequently, pain is due to tissue injury and serves to protect us from further harm, during which time healing can occur (1). This acute pain is often short-lived and can be effectively treated with analgesic medications such as opioids and nonsteroidal anti-inflammatory agents. In some instances, pain may persist as a consequence of a chronic process such as inflammation (2), invasion by tumor (3), or degeneration (4). Patients with these types of chronic pain consume large amounts of analgesics that are often ineffective for their pain, or which have undesirable, dose-related, side-effects. Chronic pain may also develop after damage to central or peripheral somatosensory pathways in humans (5). This neuropathic pain is often severe, persistent and resistant to treatment with any analgesic medication. Gene-based therapies for pain offer a potential alternative for the treatment of pain due to chronic disease or somatosensory injury. Using this approach, treatment can potentially be targeted to the site of injury, or within pain pathways, inducing analgesia without systemic side effects. Successful treatment with gene-based therapies for pain may also reduce the requirement for continuous or repeated administration of analgesics in patients with chronic pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fields, H. L. (1987) Introduction, in Pain ( Fields, H. L., ed.), McGraw Hill, NY, p. 2.
Levine, J. D. and Taiwo Y. O. (1994) Inflammatory pain, In Textbook of Pain, 3rd ed. Wall P. D. and Melzack R. eds. Churchill-Livingston, London: pp. 45–56.
Cherny, N. I. and Portenoy, R. K. Cancer pain: principles of assessment and syndromes. In P. D. Wall and R. Melzack (eds): Textbook of Pain, 3th Edition. London: Churchill-Livingston: pp. 787–823.
Scadding, J. W. (19??) Peripheral neuropathies, In Textbook of Pain, 3rd ed. Wall P. D. and Melzack R. eds. Churchill-Livingston, London: pp. 667–683.
Davar, G. and Maciewicz, R. J. (1989) Deafferentation pain syndromes. Neurol. Clin. 7, 289–304.
Dubuisson, D. and Dennis, S. G. (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4, 161–174.
Hunskaar, S. Fasmer, O. B., and Hole, K. (1985) Formalin test in mice, a useful technique for evaluating mild analgesics. J. Neurosci. Methods 14, 69–76.
Ruda, M. A., ladarola, M. J., Cohen, L. V., and Young WS 3d. (1988) In situ hybridization histochemistry and immunocytochemistry reveal an increased in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. PNAS 85, 622–626.
Iadarola, M. J., Douglass, J., Civelli, O., and Naranjo, J. R. (1988) Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Brain Res. 455, 205–221.
Schaible, H. G. and Schmidt, R. F. (1985) Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J. Neurophys. 54, 1109–1122.
Coderre, T. J. and Wall, P. D. (1988). Ankle joint urate arthritis in rats provides a useful tool for the evaluation of analgesic and anti-arthritic agents. Pharmacol. Biochem. Behavior 29, 461–466.
Sluka, K. A. and Westlund, K. N. (1993) Behavioral and immunohistochemical changes in an experimental arthritis model in rats. Pain 55, 367–377.
De Castro Costa, M., De Sutter, P., Gybels, J., and Van Hees, J. (1981) Adjuvant-induced arthritis in rats: a possible animal model of chronic pain. Pain 10, 173–185.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kloussis, D., and Kollias, G. (1991) Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO 10, 4025–4031.
Bennett, G. J. and Xie, Y. K. (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87–107.
Sommer, C. and Myers, R. R. (1994) Thalidomide inhibition of TNF reduces hyperalgesia in neuropathie rats, Abstrast of Scientific Paper presented at ASRA Annual Meeting, Session 1.
Wagner, R. and Myers, R. R. (1996a) Schwann cells produce tumor necrosis factor alpha expression in injured and non-injured nerves. Neurosci. Lett. 73, 625–629.
Wagner, R. and Myers, R. R. (1996b) Endoneurial injection of TNF-alpha or its second nessenger ceramide results in nociceptive behaviors in the rat. Abstract presented at the 8th World Congress on Pain, 353.
Sommer, C. and Marziniak, M. (1996) Experimental painful neuropathy: inhibitors of TNF-a-production induce a decrease in hyperalgesia and an increase of spinal metenkephalin. Presented at the 26th Annual Meeting of the Society for Neuroscience, 208. 6.
Wall, P. D., Devor, M., Inbal, R., Scadding, J. W., Schonfeld, D., Seltzer, Z., and Tomkiewicz, M. M. (1979) Autotomy following peripheral nerve lesions:experimental aneasthesia dolorosa. Pain 7, 103–113.
Lombard, M. C., Nashold, B. S., and Albe-Fessard, D. (1979) Deafferentation hypersensitivity in the rat after dorsal rhizotomy: possible animal model for chronic pain. Pain 6, 163–174.
Coderre, T., Grimes, R. W., and Melzack, R. (1986) Deafferentation and chronic pain in animals: an evaluation of evidence suggesting autotomy is related to pain. Pain 26, 61–84.
Attal, N., Jazat, F., Kayser, V., and Guilbaud, G. (1990) Further evidence for “pain-related” behaviors in a model of unilateral peripheral mononeuropathy. Pain 41, 235–251.
Seltzer, Z., Dubner, R., and Shir, Y. (1990) A novel behavioral model of neuropathie pain disorders produced in rats by partial sciatic nerve injury. Pain 43, 205–218.
Kim, S. H. and Chung, J. M. (1992) An experimental model for peripheral neuropathy produced by segmental nerve ligation in the rat. Pain 50, 355–363.
Basbaum, A. I., Gautron, M., Jazat, F., Mayes, M., and Guilbaud, G. (1991) The spectrum of fiber loss in a model of neuropathie pain in the rat: an electron microscopic study. Pain 47, 359–367.
Munger, B. L., Bennett, G. J., and Kajander, K. C. (1992) An experimental painful peripheral neuropathy due to nerve constriction. I. Axonal pathology in the sciatic nerve. Exp. Neurol. 118, 204–214.
Clatworthy, A. L., Illich, P. A., Castro, G. A., and Walters, E. T. (1995) Role of periaxonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathie pain. Neurosci. Lett. 184, 5–8.
Devor, M. (1994) The pathophysiology of damaged peripheral nerves. In Textbook of Pain, 3rd ed. Wall P. D. and Melzack R., (eds.), Churchill-Livingston, London pp. 79–100.
Kajander, K. C., S. Wakisaka, and Bennett, G. J. (1992) Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci. Lett. 138, 225–228.
Study, R. E. and Kral, M. G. (1996) Spontaneous action potential activity in isolated dorsal root ganglion neurons from rats with a painful neuropathy. Pain 65, 235–242.
Kim, S. H., Na, H. S., Sheen, K., and Chung, J. M. (1993) Effects of sympathectomy on a rat model of peripheral neuropathy. Pain 55, 85–92.
Hattori, M., Buse, J. B., Jackson, R. A., et al. (1986) The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex, Science 14, v. 231, 733–735. 5.
Harada, M. and Makino, S. (1992) Biology of the NOD mouse, Ann. Report of the Shionogi Research Laboratories 42, 70–99.
Hattori, M., Matsumoto, E., and Itoh, N. (1994) Modifier gene for enhancing glomerulosclerosis in BC1 [(NODxMus spretus)F1xNOD] mice. Diabetes 43, 106A.
Karasik, A. and Hattori, M. (1994) Use of animal models in the study of diabetes. In Joslin’s Diabetes Mellitus, 13th ed. Weir G. and Kahn C. R. eds., Lea and Febiger, Philadelphia: pp. 318–350.
Davar, G., Waikar, S., Eisenberg, E., Hattori, M., and Thalhammer, J. G. (1995) Behavioral evidence of thermal hyperalgesia in non-obese diabetic mice with and without insulin-dependent diabetes. Neurosci. Lett. 190, 171–174.
Czech, K. A. and Sagen, J. (1995) Update on cellular transplantation into the CNS as a novel therapy for chronic pain. Progress Neurobiol. 46, 507–529.
Wu, H. H., Wilcox, G. L., and McLoon, S. C. (1994) Implantation of AtT-20 or genetically modified AtT-20/hENK cells in the mouse spinal cord induced antinociception and opioid tolerance. J. Neurosci. 14, 4806–4814.
Saitoh, Y., Taki, T., Arita, N., Ohnishi, T., and Hayakawa, T. (1995) Cell therapy with encapsulated xenogeneic tumor cells secreting B-endorphin for treatment of peripheral pain. Cell Transplantation 4, S 13-S 17.
Breakefield, X. O., Huang, Q., Andersen, J. K., Kramer, M. F., Bebrin, W., Davar, G., Vos, B., Garber, D. A., DiFiglia, M., and Coen, D. M. (1992) Gene transfer into neurons using recombinant herpes virus vectors. Fond. IPSEN Proc. In Gene Transfer and Therapy, ( Gage, R. H. and Christen, Y. eds.), Springer-Verlag, Berlin: pp. 118–132.
Leib, D. A. and Olivo, P. D. (1993) Gene delivery to neurons: is herpes simplex virus the right tool for the job? Bioessays 15, 547–554.
Ho, D. Y. and Mocarski, E. S. (1988) (3-Galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology 167, 279–283.
Dobson, A. T., Sederati, F., Devi-Rao, G., Flanagan, W. M., Farrell, M. J., Stevens, J. G., Wagner, E. K., and Feldman, L. T. (1989) Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 63, 3844–3851.
Dobson, A. T., Margolis, T. P., Sedarati, F., Stevens, J. G., and Feldman, L. T. (1990) A latent, nonpathogenic HSV-1-derived vector stably expresses (3-galactosidase in mouse neurons. Neuron 5, 353–360.
Davar, G., Kramer, M. F., Garber, D., Roca, A. L., Andersen, J. K., Bebrin, W., Coen, D. M., Kosz-Vnenchak, M., Knipe, D. M., Breakefield, X. O., and Isacson, O. (1994) Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors. J. Comp. Neurol. 3, 393–411.
Rock, D. L. and Fraser, N. W. (1983). Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302, 523–525.
Efstathiou, S., Minson, A. C., Field, H. J., Anderson, J. R., and Wildy, P. (1986) Detection of herpes simplex virus-specific DNA sequences in latently infected mice and humans. J. Virol. 57, 446–455.
Stevens, J. G., Wagner, E. K., Devi-Rao, G. B., Cook, M. L., and Feldman, L. T. (1987) RNA complementary to a herpes virus alpha gene mRNA is prominent in latently infected neurons. Science 235, 1056–1059.
Mellerick, D. M. and Fraser, N. W. (1987) Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virol. 158, 265–275.
Coen, D. M., Kosz-Vnenchak, M., Jacobson, J. G., Leib, D. A., Bogard, C. L., Schaffer, P. A., Tyler, K. L., and Knipe, D. M. (1989) Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA 86, 4736–4740.
Slobedman, B., Efstathiou, S., and Simmons, A. (1994) Quantitative analysis of herpes simplex virus DNA and transcriptional activity in ganglia of mice latently infected with wild-type and thymidine kinase-deficient viral strains. J. Gen. Virol. 75, 2469–2474.
Davar, G., Bebrin, W. R., Dong, W., Breakefield, X. O., Coen, D. M., and Day, R. Opioid peptide gene delivery to mouse sensory neurons using herpes virus vectors. Neuroscience,in progress.
Hylden, J. L., Nahin, R. L., Traub, R. J., and Dubner, R. (1991) Effects of spinal kappa-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons. Pain 44, 187–193.
Milian, M. J. and Colpaert, F. C. (1991) Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa-but not mu-opioid receptors in the modulation of nociception, behaviour and pathology. Neuroscience. 42, 541–553.
Keita, H., Guilbaud, G., Kayser, V. (1994). Peripheral analgesic effect of a kappa opioid agonist which has limited access to CNS (ICI 204448) in rats with peripheral mononeuropathy. Eur. Neurosci. Abstr., in progress.
Wilson, S. P., Yeomans, D. C., Bender, M. A., and Glorioso, J. (1996) Delivery of enkephalins to mouse sensory neurons by a herpes virus encoding proenkephalin. [Abstract] Presented at the 26th Annual Meeting of the Society for Neuroscience, 540. 3.
Hargreaves, K. M., Dubner, R., Joris, J. (1988) Peripheral actions of opiates in the blockade of carrageenan-induced inflammation. In Proceedings of the Vth World Congress on Pain. ( Dubner, R., Gebhart, G. F., and Bond, M. R. eds), Elsevier, Amsterdam: pp. 55–60.
Stein, C., Millan, M. J., Shippenberg, T. S., and Herz, A. (1988). Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neurosci. Lett. 84, 225–228.
Dickenson, A. H. (1991). Mechanisms of the analgesic actions of opiates and opioids. Br. Med. Bull. 47, 690–702.
Dray, A. (1995) Inflammatory mediators of pain. Br. J. Anaesth. 75, 125–131.
Bonica, J. and Butler, S. H. (1994) Local anesthetics and regional blocks. In Textbook of Pain, 3rd ed., ( Wall P. D. and Melzack, R. eds), Churchill-Livingston, London: pp. 997–1023.
McQuay, H. J. Epidural analgesics. In Textbook of Pain, 3rd ed. (Wall, P. D. and Melzack, R. eds), Churchill-Livingston, London: pp. 1025–1034.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Davar, G. (1998). Gene Therapy for Pain. In: Chiocca, E.A., Breakefield, X.O. (eds) Gene Therapy for Neurological Disorders and Brain Tumors. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-478-8_20
Download citation
DOI: https://doi.org/10.1007/978-1-59259-478-8_20
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5314-1
Online ISBN: 978-1-59259-478-8
eBook Packages: Springer Book Archive